# Phase 1 stomach cancer trials recruiting: 75 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 75 trials in phase 1 for stomach cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 stomach cancer trials: 75 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/stomach-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 75
- Recruiting or not yet: 75
- Read on: November 19, 2026

## Trials

The 25 newest of 75, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 10, 2026 | NCT07928258 | A Study of LY4336619 in Adult Participants With Advanced Solid Tumors | Eli Lilly and Company | Phase 1 | Not yet recruiting | Endometrial Neoplasms, Ovarian Neoplasms, Neoplasms, Germ Cell and Embryonal, Carcinoma, Non-Small-Cell Lung, Stomach... | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928258) |
| November 6, 2026 | NCT07923396 | GK01 Cell Therapy in Gastric Cancer With Peritoneal Metastasis | Ruijin Hospital | Phase 1 | Not yet recruiting | Gastric Cancer (GC) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923396) |
| November 6, 2026 | NCT07923214 | A Phase I Dose Escalation Study of CG-7321 Monotherapy or Combination Therapy in Advanced Solid Tumors | Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. | Phase 1 | Recruiting | Advanced Solid Tumors, Breast Cancer, Ovarian Cancer, Gastric Cancer, Other Solid Tumors | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923214) |
| October 29, 2026 | NCT07903857 | SND002 Cell Injection in Participants With Advanced Malignant Solid Tumors | Guizhou Sinorda Pharmaceutical Co., Ltd. | Phase 1 | Not yet recruiting | Colorectal Neoplasms, Stomach Neoplasms, Solid Tumor Malignancies | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903857) |
| October 29, 2026 | NCT07903415 | A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors. | Pfizer | Phase 1 | Recruiting | Pancreatic Ductal Adenocarcinoma, Esophageal Cancer, Carcinoma, Non-Small-Cell Lung (NSCLC), Gastric Carcinoma... | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903415) |
| September 16, 2026 | NCT07822399 | A Study of MGC030 in Participants With Advanced Solid Tumors | MacroGenics | Phase 1 | Recruiting | Urothelial Cancer, GastroEsophageal Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer (GC), Pancreatic Cancer | 314 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822399) |
| September 10, 2026 | NCT07814248 | A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a... | TwoStep Therapeutics, Inc. | Phase 1 | Recruiting | NSCLC (Non-small Cell Lung Cancer), HNSCC, Endometrial, Ovarian Cancer, Esophageal Cancer, Head & Neck Cancer, Gastric... | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07814248) |
| September 10, 2026 | NCT07812805 | SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors | SK Life Science, Inc. | Phase 1 | Recruiting | Selected Advanced Solid Tumors, Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Biliary Tract Cancer... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07812805) |
| September 8, 2026 | NCT07807956 | A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With... | AbbVie | Phase 1 | Recruiting | Advanced Solid Tumors, Non-Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Gastric Cancer... | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07807956) |
| September 8, 2026 | NCT07807345 | Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic | Sutro Biopharma, Inc. | Phase 1 | Recruiting | Head & Neck Squamous Cell Carcinoma, Non-Small Cell Lung Cancer, Esophageal Cancer, Gastric Cancer, Colorectal Cancer... | 285 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07807345) |
| September 8, 2026 | NCT07806500 | Phase Ib Study of Oral R01 Monotherapy in Advanced Solid Tumors | Beijing Anjianxi Bio-Medical Technology Co., Ltd. | Phase 1 | Not yet recruiting | Squamous Cell Lung Cancer, Gastric Cancer, Esophageal Cancer | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07806500) |
| September 3, 2026 | NCT07801508 | A Study of \[68Ga\]Ga-DWJ155 in Adult Patients With Solid Tumors | Novartis Pharmaceuticals | Phase 1 | Recruiting | Advanced Gastroesophageal Adenocarcinoma, Advanced Breast Cancer, Triple-negative Breast Cancer, Advanced Non-small... | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07801508) |
| July 31, 2026 | NCT07738939 | IKS04 Regimen in Advanced Solid Tumors That Express CA242 | Iksuda Therapeutics Ltd. | Phase 1 | Not yet recruiting | Colorectal Cancer, Gastro Esophageal Junctional Cancer, Gastric Cancer (GC), GEJ Adenocarcinoma, PDAC - Pancreatic... | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07738939) |
| July 20, 2026 | NCT07715747 | A Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors | TJ Biopharma Co., Ltd. | Phase 1 | Recruiting | Solid Tumor, Metastatic Ovary Cancer, Metastatic Gastric Cancer, Metastatic Endometrial Carcinoma | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07715747) |
| July 15, 2026 | NCT07705334 | A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors | SHY Therapeutics | Phase 1 | Recruiting | Advanced or Metastatic Solid Tumors, Triple Negative Breast Cancer (TNBC), HR+ Breast Cancer, Colon Cancer, Gastric... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07705334) |
| June 12, 2026 | NCT07646106 | THE-0504 in Patients With Solid Tumors | Thena Biotech S.r.l. | Phase 1 | Recruiting | Small Cell Lung Cancer (SCLC), Colorectal Carcinoma (CRC), Gastric Cancer (GC), Triple -Negative Breast Cancer... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07646106) |
| May 19, 2026 | NCT07594964 | To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent... | Shenzhen Xinhe Biomedical | Phase 1 | Recruiting | Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer), Pancreatic Ductal Adenocarcinoma (PDAC), Hepatocellular... | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07594964) |
| May 18, 2026 | NCT07593820 | A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics... | Vall d'Hebron Institute of Oncology | Phase 1 | Recruiting | Metastatic Gastric Cancer, Metastatic Breast Cancer, Endometrial Cancer Metastatic | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07593820) |
| May 11, 2026 | NCT07578571 | A Phase 1 Study of IM-1617 in Participants With Advanced Cancer | Immunome, Inc. | Phase 1 | Recruiting | Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Esophageal Cancer, Stomach Cancer, Cancer | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07578571) |
| April 8, 2026 | NCT07517198 | Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors | Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | Phase 1 | Recruiting | Solid Tumor, Small Cell Lung Cancer (SCLC), High Grade Neuroendocrine Cancer, Small Cell Carcinomas of Non-lung Origin... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07517198) |
| March 18, 2026 | NCT07481357 | A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and... | Dong-A ST Co., Ltd. | Phase 1 | Recruiting | Gastric (Stomach) Cancer, GastroEsophageal Cancer, Pancreatic Ductal Adenocarcinoma (mPDAC) | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07481357) |
| February 5, 2026 | NCT07390838 | A Study of SH009 Injection in Patients With Advanced Solid Tumors. | Nanjing Sanhome Pharmaceutical, Co., Ltd. | Phase 1 | Recruiting | Liver Cancer (Locally Advanced or Metastatic), Lung Cancer (NSCLC), Head and Neck Cancer Squamous Cell Carcinoma... | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07390838) |
| January 22, 2026 | NCT07360314 | Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors | EMD Serono Research & Development Institute, Inc. | Phase 1 | Recruiting | Advanced Solid Tumors | 138 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07360314) |
| January 22, 2026 | NCT07358884 | First in Human Study of QLS5316 in Solid Tumors | Qilu Pharmaceutical Co., Ltd. | Phase 1 | Not yet recruiting | Solid Tumors, Colorectal Cancer, Gastric Cancer or Gastroesophageal Junction Adenocarcinoma, Head and Neck Squamous... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07358884) |
| January 12, 2026 | NCT07333820 | Clinical Study to Evaluate the Safety and Anti-Tumor Activity of AB-201 | Yonsei University | Phase 1 | Not yet recruiting | Malignant Neoplasm of Stomach, Unspecified | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07333820) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Chongqing Precision Biotech Co., Ltd](https://specstream.ai/data/clinical-trials/company/chongqing-precision-biotech-co-ltd) | 3 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 3 |
| [Seagen, a wholly owned subsidiary of Pfizer](https://specstream.ai/data/clinical-trials/company/seagen-a-wholly-owned-subsidiary-of-pfizer) | 3 |
| Sutro Biopharma, Inc. | 2 |
| [MacroGenics](https://specstream.ai/data/clinical-trials/company/macrogenics) | 2 |
| Iksuda Therapeutics Ltd. | 2 |
| National Cancer Institute (NCI) | 2 |
| [Sichuan Baili Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/sichuan-baili-pharmaceutical-co-ltd) | 2 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 2 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 1 |
| Peking University | 1 |
| Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 1 |
| Nurix Therapeutics, Inc. | 1 |
| Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. | 1 |
| ImmVirx Pty Ltd | 1 |
| GONGCHU Biotechnology Co., Ltd | 1 |
| TwoStep Therapeutics, Inc. | 1 |
| Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 1 |
| Fox Chase Cancer Center | 1 |
| [TJ Biopharma Co., Ltd.](https://specstream.ai/data/clinical-trials/company/tj-biopharma-co-ltd) | 1 |
| [Nanjing Sanhome Pharmaceutical, Co., Ltd.](https://specstream.ai/data/clinical-trials/company/nanjing-sanhome-pharmaceutical-co-ltd) | 1 |
| Conjupro Biotherapeutics, Inc. | 1 |
| JiaRay Group | 1 |
| ViroMissile, Inc. | 1 |
| Danatlas Pharmaceuticals Co., Ltd | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 43 |
| China | 27 |
| Japan | 9 |
| Australia | 7 |
| United Kingdom | 7 |
| South Korea | 7 |
| Spain | 7 |
| France | 5 |
| Canada | 5 |
| Germany | 4 |
| Netherlands | 3 |
| Taiwan | 3 |
| Italy | 2 |
| Israel | 2 |
| Sweden | 2 |
| New Zealand | 1 |
| Singapore | 1 |
| Switzerland | 1 |
| Belgium | 1 |
| India | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Immigration law firms in the United States](https://specstream.ai/data/businesses/immigration-law-firms/united-states)
- [Building supply stores in the United States](https://specstream.ai/data/businesses/building-supply-stores/united-states)
- [Sheet metal fabricators in the United States](https://specstream.ai/data/businesses/sheet-metal-fabricators/united-states)
- [Import and export companies in the United States](https://specstream.ai/data/businesses/import-and-export-companies/united-states)
- [Burmese restaurants in the United States](https://specstream.ai/data/businesses/burmese-restaurants/united-states)
- [Shipping collection companies in the United States](https://specstream.ai/data/businesses/shipping-collection-companies/united-states)
